• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Cilostazol use is associated with FIM cognitive improvement during convalescent rehabilitation in patients with ischemic stroke: a retrospective study.
Authors: Senda J, Ito K, Kotake T, Kanamori M, Kishimoto H, Kadono I, Nakagawa-Senda H, Wakai K, Katsuno M, Nishida Y, Ishiguro N, Sobue G Abstract Cilostazol is a phosphodiesterase III-inhibiting antiplatelet agent that is often used to prevent stroke and peripheral artery disease, and its administration has shown significant improvements for cognitive impairment. We investigate the potential of cilostazol for reducing or restoring cognitive decline during convalescent rehabilitation in patients with non-cardioembolic ischemic stroke. The study sample included 371 consecutive patients with lacunar (n = 44) and ath...
Source: Nagoya Journal of Medical Science - October 4, 2019 Category: International Medicine & Public Health Tags: Nagoya J Med Sci Source Type: research

Treatment protocol based on assessment of clot quality during endovascular thrombectomy for acute ischemic stroke using the Trevo stent retriever.
Authors: Ishikawa K, Ohshima T, Nishihori M, Imai T, Goto S, Yamamoto T, Nishizawa T, Shimato S, Kato K Abstract The optional endovascular approach for acute ischemic stroke is unclear. The Trevo stent retriever can be used as first-line treatment for fast mechanical recanalization. The authors developed a treatment protocol for acute ischemic stroke based on the assessment of clot quality during clot removal with the Trevo. This prospective single-center study included all patients admitted for acute ischemic stroke between July 2014 and February 2015, who underwent emergency endovascular treatment. According to t...
Source: Nagoya Journal of Medical Science - September 2, 2016 Category: Global & Universal Tags: Nagoya J Med Sci Source Type: research

Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review
Nagoya J Med Sci. 2023 Feb;85(1):141-149. doi: 10.18999/nagjms.85.1.141.ABSTRACTPOEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare multisystem disease characterized by plasma cell dyscrasia and overproduction of vascular endothelial growth factor, which is related to disease activity. Recent treatment strategies have improved survival of patients suffering from this disorder; however, ischemic stroke remains a poor prognostic factor. POEMS patients with ischemic stroke frequently develop cerebral large artery stenosis/occlusion, followed by progressive stroke. P...
Source: Nagoya Journal of Medical Science - March 16, 2023 Category: International Medicine & Public Health Authors: Yuki Kubota Yoshiki Hanaoka Jun-Ichi Koyama Yusuke Takahashi Nagaaki Katoh Mai Iwaya Yu Fujii Toshihiro Ogiwara Tetsuyoshi Horiuchi Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12